Efficacy and Safety of Individualized Schedule of Sunitinib by Drug Monitoring in Patients with Metastatic Renal Cell Carcinoma

PURPOSE: To investigate the survival benefit and safety of individualized schedules for sunitinib in patients with metastatic renal cell carcinoma (mRCC) through plasma concentration monitoring. METHODS: A total of 105 patients with mRCC were enrolled. The schedule was adjusted in two ways: therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xudong, Zhang, Xingming, Sun, Guangxi, Liu, Zhenhua, Zhang, Haoran, Yang, Yaojing, Ni, Yuchao, Dai, Jindong, Zhu, Sha, Chen, Junru, Zhao, Jinge, Wang, Zhipeng, Zeng, Hao, Shen, Pengfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418361/
https://www.ncbi.nlm.nih.gov/pubmed/34512023
http://dx.doi.org/10.2147/CMAR.S327029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418361/
https://www.ncbi.nlm.nih.gov/pubmed/34512023
http://dx.doi.org/10.2147/CMAR.S327029

Ejemplares similares